You have 9 free searches left this month | for more free features.

surufatinib

Showing 26 - 39 of 39

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Colorectal Cancer Trial in Fuzhou (Surufatinib)

Recruiting
  • Advanced Colorectal Cancer
  • Surufatinib
  • Fuzhou, Fujian, China
    China, Fujian
Oct 27, 2021

Safety and Efficacy of Surufatinib in Treatment of Biliary Tract

Not yet recruiting
  • Biliary Tract Carcinoma
  • Surufatinib
  • (no location specified)
Sep 22, 2021

Neuroendocrine Tumors, Non-hematologic Malignancy Trial in Japan (Surufatinib)

Recruiting
  • Neuroendocrine Tumors
  • Non-hematologic Malignancy
  • Surufatinib
  • Fukuoka, Japan
  • +11 more
Feb 1, 2022

Salivary Gland Carcinomas Trial in Shanghai (Surufatinib)

Recruiting
  • Salivary Gland Carcinomas
  • Surufatinib
  • Shanghai, China
    Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Ton
Aug 16, 2021

Neuroendocrine Tumours, Neuroendocrine Tumour of the Lung, Small Intestinal NET Trial in Worldwide (Surufatinib)

Recruiting
  • Neuroendocrine Tumours
  • +2 more
  • Surufatinib
  • Atlanta, Georgia
  • +18 more
Mar 10, 2022

Neuroendocrine Tumors Trial in Beijing, Guangzhou, Chengdu (Surufatinib, Placebo)

Active, not recruiting
  • Neuroendocrine Tumors
  • Surufatinib
  • Placebo
  • Beijing, Beijing, China
  • +4 more
Aug 30, 2021

Head Neck Cancers - Salivary Gland Trial in Shanghai (Surufatinib)

Recruiting
  • Head and Neck Cancers - Salivary Gland
  • Surufatinib
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
May 28, 2021

Healthy Trial in Dallas (surufatinib)

Completed
  • Healthy
  • surufatinib
  • Dallas, Texas
    Covance Clinical Research Unit
May 20, 2021

Neuroendocrine Tumors Trial in Beijing, Guangzhou, Chengdu (Surufatinib, Placebo)

Active, not recruiting
  • Neuroendocrine Tumors
  • Surufatinib
  • Placebo
  • Beijing, Beijing, China
  • +4 more
Apr 13, 2021

Healthy Trial in Dallas (Surufatinib, Itraconazole)

Completed
  • Healthy
  • Dallas, Texas
    Covance Clinical Research Unit
Feb 2, 2021

Thyroid Cancer Trial in Shanghai (Surufatinib, Toripalimab)

Not yet recruiting
  • Thyroid Cancer
  • Shanghai, China
    270 Dongan Road, Fudan University Shanghai Cancer Center
Aug 21, 2020

Biliary Tract Cancer Trial in Beijing (Surufatinib, Capecitabine)

Unknown status
  • Biliary Tract Cancer
  • Beijing, Beijing, China
    PLA 307 Hospital
Feb 12, 2020

Thyroid Carcinoma Trial in Beijing, Shanghai (Surufatinib)

Completed
  • Thyroid Carcinoma
  • Surufatinib
  • Beijing, Beijing, China
  • +1 more
Feb 12, 2020

Biliary Tract Cancer Trial in China (Surufatinib)

Completed
  • Biliary Tract Cancer
  • Surufatinib
  • Beijing, Beijing, China
  • +4 more
Feb 26, 2019